Introduction
and mortality of hydrocephalus. However, it is associated with potential complications including shunt failure due to obstruction, infections, and mechanical problems etc. 7, 8 The VP shunt failure may require repeated surgeries as well as multiple shunt revisions, and therefore, the management of hydrocephalus in patients with shunt failures is still a challenging problem for the neurosurgeons across the globe. 4 In the present study, we retrospectively reviewed hydrocephalus patients associated with meningioma from our institutional database to investigate the outcome of the surgical management of hydrocephalus including the incidence of VP shunt revision and its complication rates.
Materials and Methods
The study was approved by the Institutional Review Board at LSU Health Shreveport, Shreveport, Louisiana, United States. Information related to clinical history, operative reports, imaging studies, and outcomes of the patients with hydrocephalus and meningioma between 1990 and 2013 were collected retrospectively by review of the patients' charts and follow-up notes. The details of the patients' inclusion and exclusion criteria and their selection for the study are summarized in ►Fig. 1. In this series, median follow-up time was 26 months and we have lost four (8.3%) patients from the follow-up. In the present study, almost half of the tumor location was in the ventricle and petroclival region (47.5%). In this series, out of 48 patients, 14 patients received VP shunt before meningioma (ventricle and petroclival location) resection, 17 cases required VP shunt after initial resection of tumor. A total of 13 patients underwent VP shunt after second surgery of recurrent meningiomas. The cause of hydrocephalus could be intraventricular hemorrhage, blood in subarachnoid space or infection. Four patients who received Gamma Knife Radiosurgery (GKRS) as primary treatment developed hydrocephalus at late follow-up. GKRS, itself was not a predisposing factor for development of hydrocephalus in present cohort. The primary outcome of interest was the overall shunt revision rate and revision-free survival rate in hydrocephalus patients with meningioma. The overall shunt failure was defined as either revision or replacement of an existing VP shunt performed during the follow-up period.
Statistical Procedures
Commercially available software, SPSS version 21.0 (SPSS, Inc., Chicago, Illinois, United States), was used for statistical analysis. The Cox proportional hazards regression model was used to determine independent significant factors for shunt survival. The Kaplan-Meier method of survival analysis was used to estimate the overall and revision-free survival rate. The logrank (Mantel-Cox) test was used to analyze the survival difference in the cases. When necessary a chi-square test was also used. A p value of < 0.05 was considered as significant.
Results
A total of 1,018 patients who underwent shunting for hydrocephalus between 1990 and 2013 were initially screened and 249 intracranial tumor patients with VP shunt placement were taken for further screening. Of the 249 patients, 48 patients with hydrocephalus and meningiomas were included for the evaluation (►Fig. 1). Of these 48 patients, 15 (28.7%) were males and 33 (71.3%) were females, one-third (33.3%) of the patients were African Americans, and two-thirds (66.7%) were Caucasians. The median age of patients in our series was 64 years (range, 25-86 years). Overall, 12 (25%) tumors were located in the anterior cranial fossa, 7 (14.5%) tumors were in middle cranial fossa, and 23 (48%) tumors were located in the posterior cranial fossa. The average tumor volume before VP shunt placement was 5.7 cm 3 (range, 1.2-17.6 cm 3 ). Of the 48 patients, 46 (95.8%) had obstructive hydrocephalus and 2 (4.2%) patients had communicative hydrocephalus (►Table 1).
Shunt Revision
The median follow-up time of our series was 26 months. Out of 48 cases with hydrocephalus after VP shunt placement, 13 (27%) patients experienced single or multiple shunt failures requiring shunt revisions. Single shunt revision was required in eight (16.7%) patients and multiple shunt revisions were needed in five (10.4%) patients after the initial shunt placement. Moreover, after initial shunt placement, 7 (15%), 9 (19%), 11 (23%), and 13 (27%) patients developed shunt failures requiring shunt revisions within 3, 6 months, 1, and 5 years, respectively (►Table 2). 
Reasons of Shunt Revision
The most common reason for shunt revisions in hydrocephalus patients with meningioma are described in ►Table 3. A total of 26 shunt revisions were required in 13 
Factors of Shunt Survival
Shunt survival period differed based on various factors including gender, ethnicity, and procedure before shunt revision etc. The median survival period for the male patients was 39 months and the median shunt survival in the female patients was 20 months. This difference in median shunt survival time between the two groups reached statistical significance (log-rank p ¼ 0.016, ►Fig. 2). Procedure before shunt insertion (p ¼ 0.545) and ethnicity (p ¼ 0.56) did not show any significant difference in shunt survival in our case series. In Cox regression analysis, only male gender was identified as the positive predictor of shunt survival (p ¼ 0.028, ►Table 4). 
Survivability of the Patients
The overall survival in the patients with hydrocephalus associated with meningioma after 3, 5, 10, and 15 years of VP shunt placement were 75, 50, 45, and 0%, respectively, whereas revision-free survival after 3, 5, 10, and 15 years was 70, 46, 30, and 20%, respectively (►Figs. 3 and 4). In earlier time points, there was no significant difference in revisionfree survival rate compared with overall survival. However, the rate of revision-free survival was significantly higher after 15 years (20 vs. 0%, p ¼ 0.0001) compared with overall survival (►Table 5).
Predictors of Requirement of CSF Flow Diversion
Regression 
Discussion
Current treatment modalities for hydrocephalus associated with meningioma include permanent placement of VP shunts, endoscopic third ventriculostomy (ETV) or temporarily external ventricular drains. 4 Although VP shunts are beneficial for the treatment of hydrocephalus; shunt revision, removal, and 
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This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. replacement is imminent due to possible complications from the shunt itself. 7, 8 Thus, management of hydrocephalus-associated meningioma remains a great challenge to neurosurgeons and it is controversial. In this retrospective study of a cohort of 48 patients with meningioma with hydrocephalus, we analyzed the incidence of shunt failures, overall shunt survival, and predictive factors of shunt survival. This study has high potential for improving the management of hydrocephalus associated with meningiomas that are treated with VP shunts. The present study revealed that the overall incidence of shunt revision was 27% in hydrocephalus patients with meningioma. The rate of shunt revision gradually increased from 15% at 3 months to 27% at 5 years after initial shunt insertion. This study finding on incidence of shunt revision is very consistent with the previous studies.
7,9-11 The incidence of shunt revision differs considerably depending on the cause of hydrocephalus. Although our finding is consistent with earlier reports, the patient population in this study is confined to intracranial meningioma. However, present study is more comparable with other previous studies where authors reported that 27.8 and 30% patients with hydrocephalus associated with intracranial tumors required shunt revisions.
4,12
Moreover, the 6-month shunt revision rate (19%) found in our study is consistent with earlier reports (18.7 and 18.5%). 4, 13 Among overall shunt revision (27%) in our series, 23% revision was within 1st year of shunt placement. Similarly, Khan et al reported median time for shunt placement to shunt revision was 120 days and tumor-related hydrocephalus patients are more prone for shunt malfunction.
14 In this series, the cause of shunt revision within 1st year of shunt placement was either infection or obstruction. Protein level in CSF might play important role in development of shunt malfunction.
15-19
On the contrary, several reports showed that there was no association with increased CSF protein level and shunt failure. [20] [21] [22] [23] [24] [25] [26] Earlier report demonstrated that elevated level of CSF protein and subsequent deposition of that protein in VP shunt catheter did not cause obstruction of the shunt catheter.
25
Another study suggested that a high protein level in CSF did not cause to develop shunt infection 26 Most importantly, a prospective study showed that an increased CSF protein did not influence the development of shunt complications, and placement of VP shunt should not be delayed in patients with elevated CSF protein. 23 In this cohort, there was no significant difference (p ¼ 0.12) in CSF protein content between the group of patients with or without shunt revisions. This study also demonstrated how multiple factors including obstruction, infection, and complications in the proximal or distal shunt, etc., are associated with shunt failure in the patients with hydrocephalus associated with meningioma. Among the above-mentioned factors, proximal shunt complication showed the higher number of multiple revisions in our series which is consistent with previous reports. 4, 27 We have also looked into the predictors of shunt survival in the patients with hydrocephalus associated with meningioma and found that only male gender positively affects the shunt survival in these patients. Another objective of the VP shunt treatment in the patients with hydrocephalus associated with meningioma is to identify the revision-free survival. Our finding showed that the overall survival in the patients with hydrocephalus and meningioma after 3, 5, 10, and 15 years of VP shunt placement were 75, 50, 45, and 0%, respectively. However, the shunt revision-free survival after 3, 5, 10, and 15 years was 76, 46, 30, and 20%, respectively. These findings were consistent with a previous report. 4 Moreover, the rate of revision-free survival was significantly higher after 15 years (20 vs. 0%, p ¼ 0.0001) compared with overall survival. Thus, multiple shunt revision has a negative impact on the survivability of the patients with hydrocephalus and meningioma. In the past two decades, image-guided surgery is getting popularity in the field of neurosurgery, and has simplified the access to the region of surgery with minimal invasiveness, enhancement of proper shunt placement, and reduced morbidity. Wilson et al 28 reported statistically significant difference between freehand catheters and stereotactic-guided catheters (p < 0.001). With the technological advances in neuronavigation, the system became user friendly, perceptive, and able to provide real-time anatomical information. [29] [30] [31] However, neuronavigation has certain limitations including chance of unintended brain injury due to change of surgeon's view from microscope and cost. Another limitation of neuronavigation is unable to obtain a more favorable surgical position after completion of patient-to-image registration. [29] [30] [31] In this series, we have not performed neuronavigation before shunt placement, and this might have avoided some revisions. ETV has certainly become an important mode of treatment in recent years.
32-38 ETV before resection of tumor is controversial as the resection of tumor itself can lead to resolve of hydrocephalus. Moreover, it can be blocked by blood products and tumor debris. The procedure itself is not free from risks as well. But in patients where urgent management of hydrocephalus is required or patients with high risk of development of postoperative hydrocephalus, it is wise to do an ETV before resection the tumor. However, choice of ETV after resection of tumors is rewarding most of the times and less controversial. Several good literatures are available depicting the success of ETV after resection of tumors, especially for posterior fossa tumors (success rate is $90%). 39 In our center we have changed our policy keeping in track with recent developments. However, in this particular study we have only included the patients who underwent VP shunt rather than ETV since our aim was to look for predictive factors for shunt malfunction in hydrocephalus with intracranial meningioma. Adjustable or programmable valves including Polaris (Sophysa, Orsay, France), proGAV (Aesculap, Inc., Center Valley, Pennsylvania, United States) or Strata (Medtronic, Minneapolis, Minnesota, Unites States), have the characteristics of noninvasive readjustment of CSF pressure and flow in an implanted shunt. The objective of the newer adjustable valves was to aid better regulation of CSF pressure, flow, and drainage, and decrease the number of shunt failures due to underdrainage, overdrainage, and slit ventricle syndrome. 40, 41 Moreover, report has been showed that programmable valve reduced the number of proximal In the present study, we have also sought to determine the predictors of requirement of CSF flow diversion. Burkhardt et al 3 showed that patient's age, duration of surgery, duration of hospital stay, and large tumor volume, infection, and preoperative embolization were associated with occurrence of hydrocephalus after resection of meningiomas. Similarly, our data revealed that patients age ! 65 years and tumor size > 5 cm were significantly related to requirement of CSF flow diversion. In addition, although Burkhardt et al 3 did find well correlation between Simpson grades of resection and occurrence of hydrocephalus, we have found that Simpson grades II to IV resection and tumor in posterior fossa have significant correlation with requirement of CSF flow diversion. This finding is consistence with result of the pervious report. 46 However, in our series, WHO grade and postoperative infection did show any significant correlation with requirement of CSF flow diversion, which was in accord with the existing literature.
3
The present study is subject to several important limitations. One important limitation is the retrospective nature of the study that explores the long-term management of hydrocephalus in patients with meningioma. Although uniform technique for VP shunt insertion was practiced, the surgeries were performed by different neurosurgeons.
Taken together, with lower percentage of shunt revision, the results of our series revealed that VP shunting is a good option for the management of hydrocephalus in patients with meningioma. However, prospective clinical studies with a large volume of patients are warranted to identify the revision-free shunt survival rate in hydrocephalus patients with meningioma. Factors regarding the proximal shunt complication need to be identified and resolved, since the major cause of shunt revision was obstruction in the proximal shunt. Recent studies are focused on improving shunts by developing material such as antibiotic impregnation in the shunt and valve mechanisms.
47,48 In addition, other treatment modalities including endoscopic ventriculostomy or use of neuronavigation for shunt placement need to be compared with the regular VP shunt procedure to avoid shunt-related complication in meningioma patients.
